1. Home
  2. FICO vs MIST Comparison

FICO vs MIST Comparison

Compare FICO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fair Isaac Corproation

FICO

Fair Isaac Corproation

N/A

Current Price

$671.96

Market Cap

15.3B

ML Signal

N/A

Logo Milestone Pharmaceuticals Inc.

MIST

Milestone Pharmaceuticals Inc.

N/A

Current Price

$0.44

Market Cap

95.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FICO
MIST
Founded
1956
2003
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.3B
95.3M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
FICO
MIST
Price
$671.96
$0.44
Analyst Decision
Buy
Strong Buy
Analyst Count
21
7
Target Price
★ $821.37
$3.86
AVG Volume (30 Days)
700.9K
★ 1.9M
Earning Date
11-04-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.85
N/A
EPS
★ 36.32
N/A
Revenue
★ $1,032,475,000.00
N/A
Revenue This Year
$2.20
$215.89
Revenue Next Year
$6.47
$157.01
P/E Ratio
$18.62
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$595.19
$0.36
52 Week High
$1,858.91
$3.06

Technical Indicators

Market Signals
Indicator
FICO
MIST
Relative Strength Index (RSI) 38.04 31.79
Support Level $662.30 N/A
Resistance Level $760.65 $0.84
Average True Range (ATR) 33.72 0.08
MACD 1.41 -0.03
Stochastic Oscillator 25.17 17.15

Price Performance

Historical Comparison
FICO
MIST

About FICO Fair Isaac Corproation

Founded in 1956, Fair Isaac is a leading applied analytics company. It is primarily known for its FICO credit scores, a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.

Share on Social Networks: